Newsfeeds - Spark Newswire

1 minute read

Independence Contract Q3 EPS $(1.87) Misses $(1.86) Estimate, Sales $24.04M Miss $24.30M Estimate

Today, 11:14 AM

Independence Contract (NYSE:ICD) reported quarterly losses of $(1.87) per share which missed the analyst consensus estimate of $(1.86) by 0.54 percent. This is a 31.5 percent increase over losses of $(2.73) per share

ICD

19 minute read

Earnings Scheduled For November 2, 2021

By Benzinga Insights

Today, 11:14 AM

Companies Reporting Before The Bell • Thomson Reuters (NYSE:TRI) is expected to report quarterly earnings at $0.48 per share on revenue of $1.86 billion.

1 minute read

News

William Monroe Reports In 13D Filing A 20% Stake In Independence Contract Drilling

By Benzinga Newsdesk

Today, 11:14 AM

-SEC Filing

ICD

4 minute read

46 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:14 AM

Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.

AGRX

4 minute read

44 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:14 AM

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday.

ALF

2 minute read

3 Penny Stocks Insiders Are Buying

By Lisa Levin

Today, 11:14 AM

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

ATNX

4 minute read

50 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:14 AM

Gainers Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.

ADGI

2 minute read

9 Energy Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 11:14 AM

AMPY

4 minute read

44 Biggest Movers From Yesterday

By Lisa Levin

Today, 11:14 AM

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares climbed 101.9% to close at $31.50 on Monday after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.

ADVM

3 minute read

30 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 11:14 AM

Gainers Xenon Pharmaceuticals Inc. (NASDAQ: XENE) shares jumped 71.1% to $26.69 after the company announced its phase 2 study of XEN1101 for the treatment of epilepsy met all primary and secondary endpoints.

ADVM